14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 TPST stock ended at $3.73. This is 1.08% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 5.28% from a day low at $3.60 to a day high of $3.79.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Tempest Therapeutics Inc. prices

Date Open High Low Close Volume
May 06, 2024 $3.75 $3.79 $3.60 $3.73 204 262
May 03, 2024 $3.60 $3.77 $3.56 $3.69 410 243
May 02, 2024 $3.67 $3.74 $3.48 $3.54 482 016
May 01, 2024 $3.47 $3.67 $3.42 $3.62 257 169
Apr 30, 2024 $3.44 $3.54 $3.40 $3.47 239 008
Apr 29, 2024 $3.51 $3.72 $3.44 $3.44 306 168
Apr 26, 2024 $3.51 $3.63 $3.38 $3.54 401 127
Apr 25, 2024 $3.37 $3.48 $3.31 $3.48 287 166
Apr 24, 2024 $3.45 $3.57 $3.36 $3.44 652 271
Apr 23, 2024 $3.28 $3.47 $3.24 $3.42 396 508
Apr 22, 2024 $3.10 $3.28 $3.08 $3.24 388 961
Apr 19, 2024 $3.16 $3.26 $3.06 $3.10 383 692
Apr 18, 2024 $3.30 $3.34 $3.17 $3.17 315 081
Apr 17, 2024 $3.29 $3.34 $3.22 $3.27 345 302
Apr 16, 2024 $3.32 $3.44 $3.21 $3.35 470 685
Apr 15, 2024 $3.60 $3.63 $3.31 $3.34 586 276
Apr 12, 2024 $3.82 $3.86 $3.58 $3.59 456 598
Apr 11, 2024 $3.83 $3.95 $3.72 $3.85 394 560
Apr 10, 2024 $3.79 $3.90 $3.70 $3.72 459 495
Apr 09, 2024 $4.00 $4.18 $3.79 $3.87 750 122
Apr 08, 2024 $3.76 $4.18 $3.76 $3.99 777 853
Apr 05, 2024 $4.38 $4.46 $3.57 $3.72 2 494 451
Apr 04, 2024 $5.17 $5.31 $4.50 $4.50 1 669 466
Apr 03, 2024 $4.90 $5.33 $4.75 $5.13 1 069 279
Apr 02, 2024 $5.22 $6.00 $4.69 $5.09 4 682 466
Click to get the best stock tips daily for free!

About Tempest Therapeutics Inc.

Tempest Therapeutics. Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxisome proliferator-activated receptor alpha that is in a Phase 1 trial in solid tumors. It also develops T... TPST Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT